Background /Aims : We aimed
in our study to determine serum amphiregulin level, which is an indicator of a
malignancy, and to foresee pancreatic carcinoma in chronic pancreatitis.
Materials
and Methods: 42 patients who applied to Department of Gastroenterology and were diagnosed with chronic
pancreatitis and 43 healthy patients as
the control group were enrolled in the study. Serum amphiregulin levels were
studied with an Amphiregulin Human ELISA Kit ab99975 (Abcam, Cambridge, UK) by
ELISA(Enzyme-Linked Immunosorbent Assay) method.
Results:
Patients with chronic pancreatitis compared to healthy control group (p : 0.007)
and the group complicated with pseudocyst among chronic pancreatitis patient
group, serum amphiregulin level (p : 0.006) and Ca 19-9 (p : 0.03) level are
high. We also found that the relationship between the long diameter of the
pseudocyst and serum amphiregulin level is statistically significant (p : 0.01)
in the complicated chronic pancreatitis group.
Conclusion:
Patients with chronic pancreatitis and the group complicated with pseudocyst
among chronic pancreatitis patient group must be monitored more closely in
terms of pancreatic cancer since serum amphiregulin level and Ca 19-9 level are
high and the relationship between the long diameter of the pseudocyst and serum
amphiregulin level is statistically significant in such patient groups.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Original Article |
Authors | |
Publication Date | September 22, 2019 |
Published in Issue | Year 2019 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.